Exonuclease cycling assay : an amplified assay for the detection of specific DNA sequences

An assay is described in which an oligonucleotide probe is specifically digested by lambda exonuclease only when it is annealed to its complementary sequence. In this assay, a cycling effect occurs whereby a small amount of target sequence acts as a specific co-factor in the enzymatic degradation of...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:BioTechniques. - 1988. - 13(1992), 6 vom: 12. Dez., Seite 888-92
1. Verfasser: Copley, C G (VerfasserIn)
Weitere Verfasser: Boot, C
Format: Aufsatz
Sprache:English
Veröffentlicht: 1992
Zugriff auf das übergeordnete Werk:BioTechniques
Schlagworte:Journal Article Oligonucleotide Probes Viral Proteins DNA 9007-49-2 Exodeoxyribonucleases EC 3.1.- exo protein, Bacteriophage lambda EC 3.1.11.3
LEADER 01000caa a22002652 4500
001 NLM014582236
003 DE-627
005 20250124161642.0
007 tu
008 231221s1992 xx ||||| 00| ||eng c
028 5 2 |a pubmed25n0049.xml 
035 |a (DE-627)NLM014582236 
035 |a (NLM)1476740 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Copley, C G  |e verfasserin  |4 aut 
245 1 0 |a Exonuclease cycling assay  |b an amplified assay for the detection of specific DNA sequences 
264 1 |c 1992 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 11.02.1993 
500 |a Date Revised 10.12.2019 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a An assay is described in which an oligonucleotide probe is specifically digested by lambda exonuclease only when it is annealed to its complementary sequence. In this assay, a cycling effect occurs whereby a small amount of target sequence acts as a specific co-factor in the enzymatic degradation of a larger number of molecules of an oligonucleotide probe. This amplification principle is demonstrated and the effect of the oligonucleotide probe sequence investigated. The necessary steps needed to convert this effect into a useful diagnostic tool are discussed 
650 4 |a Journal Article 
650 7 |a Oligonucleotide Probes  |2 NLM 
650 7 |a Viral Proteins  |2 NLM 
650 7 |a DNA  |2 NLM 
650 7 |a 9007-49-2  |2 NLM 
650 7 |a Exodeoxyribonucleases  |2 NLM 
650 7 |a EC 3.1.-  |2 NLM 
650 7 |a exo protein, Bacteriophage lambda  |2 NLM 
650 7 |a EC 3.1.11.3  |2 NLM 
700 1 |a Boot, C  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1988  |g 13(1992), 6 vom: 12. Dez., Seite 888-92  |w (DE-627)NLM012627046  |x 0736-6205  |7 nnns 
773 1 8 |g volume:13  |g year:1992  |g number:6  |g day:12  |g month:12  |g pages:888-92 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |d 13  |j 1992  |e 6  |b 12  |c 12  |h 888-92